Impaired plasma lipid profiles in acute hepatitis
Open Access
- 23 January 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Lipids in Health and Disease
- Vol. 9 (1), 5
- https://doi.org/10.1186/1476-511x-9-5
Abstract
The present study examined plasma lipid profiles in thirty patients suffered from acute viral hepatitis. Patients' blood samples were collected at both the debut and recovery of diseases. Thirty sex and age matched normal subjects were included as controls. Plasma total triglycerides (TG), total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein AI (ApoAI), apolipoprotein B (ApoB), lipoprotein (a) (Lp(a)), blood coagulation status including prothrombin complex activity and activated partial tromboplastin time (APTT), and hepatic functions were determined by the automatic biochemical analytical instrument. It demonstrated that plasma levels of total cholesterol, HDL-C and apoAI were significantly lower in the patients at the acute phase of hepatitis than those in normal subjects, whereas plasma levels of TG and LDL-C were obviously higher in the patients than in normal subjects (P < 0.05). Moreover, we demonstrated that patients' plasma levels of total cholesterol, LDL-C, HDL-C and apoAI were lower at the active phase of the diseases than at the recovering phase, which indicating that acute liver damage could significant influence lipid metabolism in vivo. No pathological changes of blood coagulation status occurred in these patients during the study as all selected patients had moderate hepatitis. It may conclude that examinations of plasma lipid profile could be considered as a clinical index to reflect liver damage in the active phase of hepatitis.Keywords
This publication has 20 references indexed in Scilit:
- Naltrexone Protects Against Lipopolysaccharide/D-Galactosamine–Induced Hepatitis in MiceJournal of Pharmacological Sciences, 2008
- Acquired apolipoprotein B deficiency with chronic hepatitis C virus infection.2007
- Assessment of Nutritional Status and Prediction of Postoperative Liver Function from Serum Apolioprotein A‐1 Levels with HepatectomyWorld Journal of Surgery, 2006
- Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the ratHepatology, 1999
- Reactive oxygen species and nitric oxide in viral diseasesBiological Trace Element Research, 1997
- Low lipoprotein (a) levels during acute viral hepatitisHepatology, 1996
- Alcoholic liver diseaseThe Lancet, 1995
- Apolipoproteins A-I, A-II and B in chronic active hepatitis and in liver cirrhotic patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Lipid metabolism in liver and selected tissues and in the whole body of ruminant animalsProgress in Lipid Research, 1979
- Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease.Journal of Clinical Pathology, 1978